Founded in 2017 by two respiratory clinicians following 11 yrs of NHS-led and funded research.
To improve the lives of people with COPD through life-changing digital predictive solutions that prevent 50% of COPD-related hospitalisations and re-admissions.
To be a global leader in personalised prediction and prevention of COPD exacerbations: making a difference to the lives of people with COPD
Clinical studies demonstrated 97% reduction in hospital admissions using predict to prevent intervention as part of proactive self-management.
Patients, clinicians, hospitals, policy makers and Industry provide a robust eco-system to ensure our products remain cutting edge and competitive.
NEPeSMO offers a smart CE-marked digital monitoring solution with analytics for the prediction of COPD exacerbations and prevention of hospitalisations. COPDPredict™ has been co-designed with patients and is bespoke to patients living with COPD. Proprietary prediction algorithms are constructed from time-series data on symptoms, lung function and biomarkers in blood/saliva supplied by patients using a bespoke App that connects wirelessly to monitoring devices. A dedicated web-based Clinician Early Warning System provides the healthcare team with real-time information on their patients and alerts on impending exacerbations, allowing prompt intervention.
Aspects of COPDPredict™ are patent-protected: US 8,812,249 B2; Canada 2,766,699 C and EP 2446386 B1.
“I found it very straightforward… I’m not brilliant with electronics but yes I found it very easy very straightforward”
“I like to share my progress with my family …it gives them greater understanding of my condition”
“One of the things that I found most useful was to see the results of my daily diary , my results in graphic form, so easy to see”
“I’m more confident about my self-management”
“before I didn’t even look at the colour of my sputum or think about how I feel but I do now”
“it gives you more confidence and direction”
30 yrs+ experience in the Pharma Industry with strong business leadership and corporate development roles in public & private companies in UK and USA. Previous positions: CEO Open Orphan PLC, Executive Chairman hVIVO PLC; CEO & COO Vectura Group PLC, CEO & COO Critical Therapeutics Inc.
Respiratory physician with 30 yrs+ experience working in the NHS. Named inventor on patents. Held executive leadership roles in European Respiratory and British Thoracic Societies. External advisor, EC Horizon 2020 Personalising Healthcare and various pharmaceutical companies.
Respiratory physician, named inventor on patents. 10 years’ experience in managing project finances/records and research background in saliva diagnostics and prediction algorithm construction.
Experienced founder of UK start-up SW company. 15 years+ experience in innovative software solutions and specialist in AI and IoT driven applications in healthcare.
Extensive US & international commercialisation experience in a number of senior roles, including EVP of Commercial and Business Development at Vectura Group PLC, VP Sales and Marketing at Critical Therapeutics, Inc. and VP director of client service at McK Healthcare.
76 King Street,
Manchester, M2 4NH,
TC Group, Level 1, Devonshire House,
One Mayfair Place,
London W1J 8AJ